United Asset Strategies’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,830
| Closed | -$8.64K | – | 240 |
|
|
2024
Q1 | $8.64K | Hold |
1,830
| – | – | ﹤0.01% | 234 |
|
|
2023
Q4 | $8.42K | Hold |
1,830
| – | – | ﹤0.01% | 234 |
|
|
2023
Q3 | $4.76K | Hold |
1,830
| – | – | ﹤0.01% | 229 |
|
|
2023
Q2 | $8.85K | Hold |
1,830
| – | – | ﹤0.01% | 228 |
|
|
2023
Q1 | $12.1K | Hold |
1,830
| – | – | ﹤0.01% | 221 |
|
|
2022
Q4 | $20.3K | Hold |
1,830
| – | – | ﹤0.01% | 224 |
|
|
2022
Q3 | $14K | Hold |
1,830
| – | – | ﹤0.01% | 205 |
|
|
2022
Q2 | $11K | Hold |
1,830
| – | – | ﹤0.01% | 205 |
|
|
2022
Q1 | $45K | Buy |
+1,830
| New | +$45K | 0.01% | 205 |
|